PAI Partners has submitted an improved offer for Sanofi’s consumer health business, people familiar with the matter saidThursday - Revised offer came after Sanofi
agreed to sell controlling stake in Opella to CD&R
- Revised offer came after Sanofi
- Revised offer being made “outside the timeframe and the governance process that framed the decision,” spokesperson says
- All suitors had same amount of time to make their best bids: spokesperson
- Process for finding partner for Opella “has been a long one,” spokesperson says
- NOTE:
CD&R Said to ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.